The importance of dose and schedule in cancer chemotherapy: epithelial ovarian cancer.
Anticancer Drugs
; 6 Suppl 5: 29-41, 1995 Oct.
Article
em En
| MEDLINE
| ID: mdl-8845493
ABSTRACT
Selection of specific appropriate drugs has been facilitated by a series of randomised clinical trials confirmed by overview analysis. Hitherto these issues have dominated the debate over optimal chemotherapy management of advanced ovarian cancer. The impact of true dose escalation therapy is yet to be evaluated but appears to be worthy of examination in demonstrably chemosensitive disease.
Buscar no Google
Coleções:
01-internacional
Base de dados:
MEDLINE
Assunto principal:
Neoplasias Ovarianas
/
Neoplasias Epiteliais e Glandulares
/
Antineoplásicos
Tipo de estudo:
Clinical_trials
Limite:
Female
/
Humans
Idioma:
En
Revista:
Anticancer Drugs
Assunto da revista:
ANTINEOPLASICOS
Ano de publicação:
1995
Tipo de documento:
Article
País de afiliação:
Reino Unido